• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Trimetazidine Dihydrochloride

Trimetazidine Dihydrochloride

Product ID T7133
Cas No. 13171-25-0
Purity ≥99%
Product Unit SizeCostQuantityStock
250 mg $52.50 In stock
1 g $84.00 In stock
5 g $131.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Trimetazidine is a compound that exhibits anti-anginal, anti-ischemic, and cardioprotective activities; it inhibits long-chain 3-ketoacyl-CoA thiolase. Trimetazidine reverses pro-inflammatory effects of TNF-α in animal models, including preventing decreases in myosin heavy chain production and myotube size. Trimetazidine prevents muscle wasting and atrophy; its mechanism may involve activation of Akt/mTOR2 signaling. In animal models of ischemia/reperfusion, trimetazidine decreases superoxide generation and caspase-3 activity, decreasing infarct size. In clinical settings, this compound decreases free fatty acid oxidation, improving cardiac function, insulin sensitivity, and glucose control. Trimetazidine also treats vertigo and may act as an antagonist at kainate and AMPA receptors.

Product Info

Cas No.

13171-25-0

Purity

≥99%

Formula

C14H22N2O3•2HCl

Formula Wt.

339.26

Chemical Name

1-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride

IUPAC Name

1-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride

Synonym

Trimetazidine Hydrochloride

Appearance

White Odorless Crystalline Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

T7133 MSDS PDF

Info Sheet

T7133 Info Sheet PDF

References

Ferraro E, Giammarioli AM, Caldarola S, et al. The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes. FEBS J. 2013 Oct;280(20):5094-108. PMID: 23953053.

Khan M, Meduru S, Mostafa M, et al. Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling. J Pharmacol Exp Ther. 2010 May;333(2):421-9. PMID: 20167841.

Tuunanen H, Engblom E, Naum A, et al. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation. 2008 Sep 16;118(12):1250-8. PMID: 18765391.

Dayanithi G, Desmadryl G, Travo C, et al. Trimetazidine modulates AMPA/kainate receptors in rat vestibular ganglion neurons. Eur J Pharmacol. 2007 Nov 21;574(1):8-14. PMID: 17658512.

Demaison L, Fantini E, Sentex E, et al. Trimetazidine: in vitro influence on heart mitochondrial function. Am J Cardiol. 1995 Aug 24;76(6):31B-37B. PMID: 7645525.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • K1655

    Kenpaullone

    GSK-3β, HGK, and CDK inhibitor.

    ≥95%
  • C2951

    Chlortetracycline Hydrochloride

    Tetracycline; protein translation inhibitor, MM...

    ≥85%
  • D564090

    7-epi-Docetaxel

    Docetaxel impurity

    ≥95%
  • A9617

    Azelnidipine

    Dihydropyridine; L-type Ca2+ channel blocker. &...
    ≥98%
  • R5878

    Rotenone

    Micronuclei formation inducer, antimitotic, oxi...

    ≥97%
  • B6957

    Bromhexine Hydrochloride

    Synthetic derivative of vasicine, mucolytic.

    ≥98%
  • P2857

    Phorbol-12-myristate-13-acetate

    PKC activator, carcinogen.

    ≥98%
  • R2788

    RGW-611

    Morpholine derivative.

    ≥98%
  • T564098

    Tocored

    Tocopherol analog

  • T0091

    7-(Triethylsilyl)-10-deacetylbaccatin III

    Taxol derivative.

    ≥97%
  • V3345

    Vildagliptin

    DPP4 inhibitor.

    ≥98%
  • J0274

    Jasplakinolide

    Marine toxin; actin polymerization inducer.

    ≥98%
  • M5876

    Motesanib

    VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.

    ≥98%
  • E7556

    Etodolac

    NSAID; TRPA1 agonist, COX-2 inhibitor.

    ≥98%
  • R5772

    Rosiglitazone Maleate

    Thiazolidinedione; PPARγ agonist.

    ≥98%
  • T0152

    Tandutinib

    FLT3, PDGFR, c-Kit inhibitor.

    ≥98%
  • T5761

    Topotecan Hydrochloride

    Captothecin derivative; topoisomerase I inhibit...

    ≥97%
  • T1676

    L-Tetrahydropalmatine

    Alkaloid found in Corydalis and Stephania; D1/2...

    ≥98%
  • N4974

    NMS-E628

    ALK and Ros1 inhibitor, Trk antagonist.

    ≥98%
  • P7020

    Prednisone

    Synthetic prednisolone prodrug; glucocorticoid ...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only